Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate

  1. Wan Hua Li
  2. Ke Huang
  3. Yang Cai
  4. Qian Wen Wang
  5. Wen Jie Zhu
  6. Yun Nan Hou
  7. Sujing Wang
  8. Sheng Cao
  9. Zhi Ying Zhao
  10. Xu Jie Xie
  11. Yang Du
  12. Chi-Sing Lee  Is a corresponding author
  13. Hon Cheung Lee  Is a corresponding author
  14. Hongmin Zhang  Is a corresponding author
  15. Yong Juan Zhao  Is a corresponding author
  1. The Chinese University of Hong Kong (Shenzhen), China
  2. Hong Kong Baptist University, China
  3. Southern University of Science and Technology, China
  4. Peking University Shenzhen Graduate School, China

Abstract

SARM1 regulates axonal degeneration through its NAD-metabolizing activity and is a drug target for neurodegenerative disorders. We designed and synthesized fluorescent conjugates of styryl derivative with pyridine to serve as substrates of SARM1, which exhibited large red-shifts after conversion. With the conjugates, SARM1 activation was visualized in live cells following elevation of endogenous NMN or treatment with a cell-permeant NMN-analog. In neurons, imaging documented mouse SARM1 activation preceded vincristine-induced axonal degeneration by hours. Library screening identified a derivative of nisoldipine as a covalent inhibitor of SARM1 that reacted with the cysteines, especially Cys311 in its ARM domain and blocked its NMN-activation, protecting axons from degeneration. The Cryo-EM structure showed that SARM1 was locked into an inactive conformation by the inhibitor, uncovering a potential neuroprotective mechanism of dihydropyridines.

Data availability

Diffraction data have been deposited in PDB under the accession code 7DJT. All data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated

Article and author information

Author details

  1. Wan Hua Li

    School of Life and Health Sciences, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China
    Competing interests
    No competing interests declared.
  2. Ke Huang

    Department of Chemistry, Hong Kong Baptist University, Hong Kong, China
    Competing interests
    No competing interests declared.
  3. Yang Cai

    Department of Biology, Southern University of Science and Technology, Shenzhen, China
    Competing interests
    No competing interests declared.
  4. Qian Wen Wang

    School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
    Competing interests
    No competing interests declared.
  5. Wen Jie Zhu

    School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
    Competing interests
    No competing interests declared.
  6. Yun Nan Hou

    School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
    Competing interests
    No competing interests declared.
  7. Sujing Wang

    School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
    Competing interests
    No competing interests declared.
  8. Sheng Cao

    School of Life and Health Sciences, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China
    Competing interests
    No competing interests declared.
  9. Zhi Ying Zhao

    School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
    Competing interests
    No competing interests declared.
  10. Xu Jie Xie

    School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
    Competing interests
    No competing interests declared.
  11. Yang Du

    School of Life and Health Sciences, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China
    Competing interests
    No competing interests declared.
  12. Chi-Sing Lee

    Department of Chemistry, Hong Kong Baptist University, Hong Kong, China
    For correspondence
    cslee-chem@hkbu.edu.hk
    Competing interests
    No competing interests declared.
  13. Hon Cheung Lee

    School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
    For correspondence
    leehoncheung@gmail.com
    Competing interests
    No competing interests declared.
  14. Hongmin Zhang

    Department of Biology, Southern University of Science and Technology, Shenzhen, China
    For correspondence
    zhanghm@sustech.edu.cn
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4356-3615
  15. Yong Juan Zhao

    School of Life and Health Sciences, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China
    For correspondence
    zhaoyongjuan@cuhk.edu.cn
    Competing interests
    Yong Juan Zhao, Two Chinese patents (202010528147.3; 202011359354.7) are in the process of application..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4564-1912

Funding

Ministry of Science and Technology of the People's Republic of China (2019YFA090600)

  • Hongmin Zhang

National Science Foundation of China (31871401)

  • Yong Juan Zhao

Hong Kong Baptist University (RC-SGT2/18-19/SCI/005)

  • Chi-Sing Lee

Hong Kong Baptist University (RC-ICRS-18-19-01A)

  • Chi-Sing Lee

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Hening Lin, Cornell University, United States

Ethics

Animal experimentation: This study was carried out in strict accordance with animal use protocol approved by Peking University Shenzhen Graduate School Animal Care and Use Committee (#AP0015001). All animals (C57BL6/J), purchased from Guangdong Medical Laboratory Animal Center (China), were handled in accordance with the guidelines of the Committee on the Ethic of Animal Experiments. All surgery was performed after euthanasia and efforts were made to minimize suffering.

Version history

  1. Received: February 9, 2021
  2. Accepted: May 2, 2021
  3. Accepted Manuscript published: May 4, 2021 (version 1)
  4. Version of Record published: May 24, 2021 (version 2)

Copyright

© 2021, Li et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,929
    Page views
  • 833
    Downloads
  • 34
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wan Hua Li
  2. Ke Huang
  3. Yang Cai
  4. Qian Wen Wang
  5. Wen Jie Zhu
  6. Yun Nan Hou
  7. Sujing Wang
  8. Sheng Cao
  9. Zhi Ying Zhao
  10. Xu Jie Xie
  11. Yang Du
  12. Chi-Sing Lee
  13. Hon Cheung Lee
  14. Hongmin Zhang
  15. Yong Juan Zhao
(2021)
Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate
eLife 10:e67381.
https://doi.org/10.7554/eLife.67381

Share this article

https://doi.org/10.7554/eLife.67381

Further reading

    1. Biochemistry and Chemical Biology
    Jake W Anderson, David Vaisar ... Natalie G Ahn
    Research Article

    Activation of the extracellular signal-regulated kinase-2 (ERK2) by phosphorylation has been shown to involve changes in protein dynamics, as determined by hydrogen-deuterium exchange mass spectrometry (HDX-MS) and NMR relaxation dispersion measurements. These can be described by a global exchange between two conformational states of the active kinase, named ‘L’ and ‘R,’ where R is associated with a catalytically productive ATP-binding mode. An ATP-competitive ERK1/2 inhibitor, Vertex-11e, has properties of conformation selection for the R-state, revealing movements of the activation loop that are allosterically coupled to the kinase active site. However, the features of inhibitors important for R-state selection are unknown. Here, we survey a panel of ATP-competitive ERK inhibitors using HDX-MS and NMR and identify 14 new molecules with properties of R-state selection. They reveal effects propagated to distal regions in the P+1 and helix αF segments surrounding the activation loop, as well as helix αL16. Crystal structures of inhibitor complexes with ERK2 reveal systematic shifts in the Gly loop and helix αC, mediated by a Tyr-Tyr ring stacking interaction and the conserved Lys-Glu salt bridge. The findings suggest a model for the R-state involving small movements in the N-lobe that promote compactness within the kinase active site and alter mobility surrounding the activation loop. Such properties of conformation selection might be exploited to modulate the protein docking interface used by ERK substrates and effectors.

    1. Biochemistry and Chemical Biology
    Anne E Hultgren, Nicole MF Patras, Jenna Hicks
    Feature Article

    Organizations that fund research are keen to ensure that their grant selection processes are fair and equitable for all applicants. In 2020, the Arnold and Mabel Beckman Foundation introduced blinding to the first stage of the process used to review applications for Beckman Young Investigator (BYI) awards: applicants were instructed to blind the technical proposal in their initial Letter of Intent by omitting their name, gender, gender-identifying pronouns, and institutional information. Here we examine the impact of this change by comparing the data on gender and institutional prestige of the applicants in the first four years of the new policy (BYI award years 2021–2024) with data on the last four years of the old policy (2017–2020). We find that under the new policy, the distribution of applicants invited to submit a full application shifted from those affiliated with institutions regarded as more prestigious to those outside of this group, and that this trend continued through to the final program awards. We did not find evidence of a shift in the distribution of applicants with respect to gender.